Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
Ocular Immunology and Inflammation
|
October 14, 2022
Anti-retinal Antibodies in Sarcoidosis
Carmen L Avendaño-Monje, Miguel Cordero-Coma, José L Mauriz, et al.
Seminars in Arthritis and Rheumatism
|
April 11, 2016
Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients
Vanesa Calvo-Río, Ricardo Blanco, Montserrat Santos-Gómez, et al.
Ocular Immunology and Inflammation
|
August 15, 2014
Clinical Manifestations and Outcomes of Syphilis-associated Uveitis in Northern Spain
Alex Fonollosa, Lorea Martinez-Indart, Joseba Artaraz, et al.
Clinical and Experimental Rheumatology
|
January 6, 2018
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review
Natalia Palmou-Fontana, Vanesa Calvo-Río, José Luis Martín-Varillas, et al.
Clinical and Experimental Rheumatology
|
April 22, 2021
Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes
Belén Atienza-Mateo, Emma Beltrán, Marisa Hernández-Garfella, et al.
Mediators of Inflammation
|
February 4, 2014
Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis
Carmen García-De-Vicuña, Manuel Díaz-Llopis, David Salom, et al.
Ophthalmology
|
April 25, 2012
Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients
Manuel Díaz-Llopis, David Salom, Carmen Garcia-de-Vicuña, et al.
Molecular Vision
|
April 6, 2013
Lack of association between the protein tyrosine phosphatase non-receptor type 22 R263Q and R620W functional genetic variants and endogenous non-anterior uveitis
María Carmen Cénit, Ana Márquez, Miguel Cordero-Coma, et al.
Clinical and Experimental Rheumatology
|
April 8, 2016
The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study
Montserrat Santos-Gómez, Vanesa Calvo-Río, Ricardo Blanco, et al.
BMC Medical Genetics
|
May 17, 2013
Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition
María Carmen Cénit, Ana Márquez, Miguel Cordero-Coma, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
Ocular Immunology and Inflammation
|
October 14, 2022
Anti-retinal Antibodies in Sarcoidosis
Carmen L Avendaño-Monje, Miguel Cordero-Coma, José L Mauriz, et al.
Seminars in Arthritis and Rheumatism
|
April 11, 2016
Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients
Vanesa Calvo-Río, Ricardo Blanco, Montserrat Santos-Gómez, et al.
Ocular Immunology and Inflammation
|
August 15, 2014
Clinical Manifestations and Outcomes of Syphilis-associated Uveitis in Northern Spain
Alex Fonollosa, Lorea Martinez-Indart, Joseba Artaraz, et al.
Clinical and Experimental Rheumatology
|
January 6, 2018
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review
Natalia Palmou-Fontana, Vanesa Calvo-Río, José Luis Martín-Varillas, et al.
Clinical and Experimental Rheumatology
|
April 22, 2021
Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes
Belén Atienza-Mateo, Emma Beltrán, Marisa Hernández-Garfella, et al.
Mediators of Inflammation
|
February 4, 2014
Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis
Carmen García-De-Vicuña, Manuel Díaz-Llopis, David Salom, et al.
Ophthalmology
|
April 25, 2012
Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients
Manuel Díaz-Llopis, David Salom, Carmen Garcia-de-Vicuña, et al.
Molecular Vision
|
April 6, 2013
Lack of association between the protein tyrosine phosphatase non-receptor type 22 R263Q and R620W functional genetic variants and endogenous non-anterior uveitis
María Carmen Cénit, Ana Márquez, Miguel Cordero-Coma, et al.
Clinical and Experimental Rheumatology
|
April 8, 2016
The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study
Montserrat Santos-Gómez, Vanesa Calvo-Río, Ricardo Blanco, et al.
BMC Medical Genetics
|
May 17, 2013
Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition
María Carmen Cénit, Ana Márquez, Miguel Cordero-Coma, et al.
Page
of 8